purchase customization

1 Introduction to Research & Analysis Reports
1.1 Chemotherapy-Induced Nausea and Vomiting Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Chemotherapy-Induced Nausea and Vomiting Drugs Overall Market Size
2.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Size: 2022 VS 2032
2.2 Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, Prospects & Forecasts: 2018-2032
2.3 Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales: 2018-2032
3 Company Landscape
3.1 Top Chemotherapy-Induced Nausea and Vomiting Drugs Players in Global Market
3.2 Top Global Chemotherapy-Induced Nausea and Vomiting Drugs Companies Ranked by Revenue
3.3 Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Companies
3.4 Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Companies
3.5 Global Chemotherapy-Induced Nausea and Vomiting Drugs Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Chemotherapy-Induced Nausea and Vomiting Drugs Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Chemotherapy-Induced Nausea and Vomiting Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Chemotherapy-Induced Nausea and Vomiting Drugs Players in Global Market
3.8.1 List of Global Tier 1 Chemotherapy-Induced Nausea and Vomiting Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Chemotherapy-Induced Nausea and Vomiting Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Size Markets, 2022 & 2032
4.1.2 Existing Drugs
4.1.3 Akynzeo (Netupitant-Palonosetron FDC)
4.1.4 Aloxi (Palonosetron)
4.1.5 Emend (Aprepitant)
4.1.6 Kytril Generic (Granisetron)
4.1.7 Zofran Generic (Ondansetron)
4.1.8 Pipeline Drugs
4.1.9 SUSTOL (Granisetron Injection extended release)
4.1.10 Rolapitant
4.2 By Type - Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue & Forecasts
4.2.1 By Type - Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, 2018-2023
4.2.2 By Type - Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, 2024-2032
4.2.3 By Type - Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share, 2018-2032
4.3 By Type - Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales & Forecasts
4.3.1 By Type - Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales, 2018-2023
4.3.2 By Type - Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales, 2024-2032
4.3.3 By Type - Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share, 2018-2032
4.4 By Type - Global Chemotherapy-Induced Nausea and Vomiting Drugs Price (Manufacturers Selling Prices), 2018-2032
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Size, 2022 & 2032
5.1.2 Serotonin Receptor Antagonists
5.1.3 NK1 Receptor Antagonists
5.2 By Application - Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue & Forecasts
5.2.1 By Application - Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, 2018-2023
5.2.2 By Application - Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, 2024-2032
5.2.3 By Application - Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share, 2018-2032
5.3 By Application - Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales & Forecasts
5.3.1 By Application - Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales, 2018-2023
5.3.2 By Application - Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales, 2024-2032
5.3.3 By Application - Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share, 2018-2032
5.4 By Application - Global Chemotherapy-Induced Nausea and Vomiting Drugs Price (Manufacturers Selling Prices), 2018-2032
6 Sights by Region
6.1 By Region - Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Size, 2022 & 2032
6.2 By Region - Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue & Forecasts
6.2.1 By Region - Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, 2018-2023
6.2.2 By Region - Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, 2024-2032
6.2.3 By Region - Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share, 2018-2032
6.3 By Region - Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales & Forecasts
6.3.1 By Region - Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales, 2018-2023
6.3.2 By Region - Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales, 2024-2032
6.3.3 By Region - Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share, 2018-2032
6.4 North America
6.4.1 By Country - North America Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, 2018-2032
6.4.2 By Country - North America Chemotherapy-Induced Nausea and Vomiting Drugs Sales, 2018-2032
6.4.3 US Chemotherapy-Induced Nausea and Vomiting Drugs Market Size, 2018-2032
6.4.4 Canada Chemotherapy-Induced Nausea and Vomiting Drugs Market Size, 2018-2032
6.4.5 Mexico Chemotherapy-Induced Nausea and Vomiting Drugs Market Size, 2018-2032
6.5 Europe
6.5.1 By Country - Europe Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, 2018-2032
6.5.2 By Country - Europe Chemotherapy-Induced Nausea and Vomiting Drugs Sales, 2018-2032
6.5.3 Germany Chemotherapy-Induced Nausea and Vomiting Drugs Market Size, 2018-2032
6.5.4 France Chemotherapy-Induced Nausea and Vomiting Drugs Market Size, 2018-2032
6.5.5 U.K. Chemotherapy-Induced Nausea and Vomiting Drugs Market Size, 2018-2032
6.5.6 Italy Chemotherapy-Induced Nausea and Vomiting Drugs Market Size, 2018-2032
6.5.7 Russia Chemotherapy-Induced Nausea and Vomiting Drugs Market Size, 2018-2032
6.5.8 Nordic Countries Chemotherapy-Induced Nausea and Vomiting Drugs Market Size, 2018-2032
6.5.9 Benelux Chemotherapy-Induced Nausea and Vomiting Drugs Market Size, 2018-2032
6.6 Asia
6.6.1 By Region - Asia Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, 2018-2032
6.6.2 By Region - Asia Chemotherapy-Induced Nausea and Vomiting Drugs Sales, 2018-2032
6.6.3 China Chemotherapy-Induced Nausea and Vomiting Drugs Market Size, 2018-2032
6.6.4 Japan Chemotherapy-Induced Nausea and Vomiting Drugs Market Size, 2018-2032
6.6.5 South Korea Chemotherapy-Induced Nausea and Vomiting Drugs Market Size, 2018-2032
6.6.6 Southeast Asia Chemotherapy-Induced Nausea and Vomiting Drugs Market Size, 2018-2032
6.6.7 India Chemotherapy-Induced Nausea and Vomiting Drugs Market Size, 2018-2032
6.7 South America
6.7.1 By Country - South America Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, 2018-2032
6.7.2 By Country - South America Chemotherapy-Induced Nausea and Vomiting Drugs Sales, 2018-2032
6.7.3 Brazil Chemotherapy-Induced Nausea and Vomiting Drugs Market Size, 2018-2032
6.7.4 Argentina Chemotherapy-Induced Nausea and Vomiting Drugs Market Size, 2018-2032
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, 2018-2032
6.8.2 By Country - Middle East & Africa Chemotherapy-Induced Nausea and Vomiting Drugs Sales, 2018-2032
6.8.3 Turkey Chemotherapy-Induced Nausea and Vomiting Drugs Market Size, 2018-2032
6.8.4 Israel Chemotherapy-Induced Nausea and Vomiting Drugs Market Size, 2018-2032
6.8.5 Saudi Arabia Chemotherapy-Induced Nausea and Vomiting Drugs Market Size, 2018-2032
6.8.6 UAE Chemotherapy-Induced Nausea and Vomiting Drugs Market Size, 2018-2032
7 Manufacturers & Brands Profiles
7.1 Merck & Co., Inc.
7.1.1 Merck & Co., Inc. Company Summary
7.1.2 Merck & Co., Inc. Business Overview
7.1.3 Merck & Co., Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Major Product Offerings
7.1.4 Merck & Co., Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Sales and Revenue in Global (2018-2023)
7.1.5 Merck & Co., Inc. Key News & Latest Developments
7.2 GlaxoSmithKline plc
7.2.1 GlaxoSmithKline plc Company Summary
7.2.2 GlaxoSmithKline plc Business Overview
7.2.3 GlaxoSmithKline plc Chemotherapy-Induced Nausea and Vomiting Drugs Major Product Offerings
7.2.4 GlaxoSmithKline plc Chemotherapy-Induced Nausea and Vomiting Drugs Sales and Revenue in Global (2018-2023)
7.2.5 GlaxoSmithKline plc Key News & Latest Developments
7.3 Tesaro, Inc.
7.3.1 Tesaro, Inc. Company Summary
7.3.2 Tesaro, Inc. Business Overview
7.3.3 Tesaro, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Major Product Offerings
7.3.4 Tesaro, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Sales and Revenue in Global (2018-2023)
7.3.5 Tesaro, Inc. Key News & Latest Developments
7.4 Helsinn Group
7.4.1 Helsinn Group Company Summary
7.4.2 Helsinn Group Business Overview
7.4.3 Helsinn Group Chemotherapy-Induced Nausea and Vomiting Drugs Major Product Offerings
7.4.4 Helsinn Group Chemotherapy-Induced Nausea and Vomiting Drugs Sales and Revenue in Global (2018-2023)
7.4.5 Helsinn Group Key News & Latest Developments
7.5 F. Hoffmann-La Roche Ltd.
7.5.1 F. Hoffmann-La Roche Ltd. Company Summary
7.5.2 F. Hoffmann-La Roche Ltd. Business Overview
7.5.3 F. Hoffmann-La Roche Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Major Product Offerings
7.5.4 F. Hoffmann-La Roche Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales and Revenue in Global (2018-2023)
7.5.5 F. Hoffmann-La Roche Ltd. Key News & Latest Developments
7.6 Heron Therapeutics, Inc.
7.6.1 Heron Therapeutics, Inc. Company Summary
7.6.2 Heron Therapeutics, Inc. Business Overview
7.6.3 Heron Therapeutics, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Major Product Offerings
7.6.4 Heron Therapeutics, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Sales and Revenue in Global (2018-2023)
7.6.5 Heron Therapeutics, Inc. Key News & Latest Developments
7.7 Dr. Reddy's Laboratories Ltd.
7.7.1 Dr. Reddy's Laboratories Ltd. Company Summary
7.7.2 Dr. Reddy's Laboratories Ltd. Business Overview
7.7.3 Dr. Reddy's Laboratories Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Major Product Offerings
7.7.4 Dr. Reddy's Laboratories Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales and Revenue in Global (2018-2023)
7.7.5 Dr. Reddy's Laboratories Ltd. Key News & Latest Developments
7.8 Acacia Pharma
7.8.1 Acacia Pharma Company Summary
7.8.2 Acacia Pharma Business Overview
7.8.3 Acacia Pharma Chemotherapy-Induced Nausea and Vomiting Drugs Major Product Offerings
7.8.4 Acacia Pharma Chemotherapy-Induced Nausea and Vomiting Drugs Sales and Revenue in Global (2018-2023)
7.8.5 Acacia Pharma Key News & Latest Developments
7.9 Sun Pharmaceutical Industry Ltd.
7.9.1 Sun Pharmaceutical Industry Ltd. Company Summary
7.9.2 Sun Pharmaceutical Industry Ltd. Business Overview
7.9.3 Sun Pharmaceutical Industry Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Major Product Offerings
7.9.4 Sun Pharmaceutical Industry Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales and Revenue in Global (2018-2023)
7.9.5 Sun Pharmaceutical Industry Ltd. Key News & Latest Developments
7.10 Otsuka Holdings Co., Ltd.
7.10.1 Otsuka Holdings Co., Ltd. Company Summary
7.10.2 Otsuka Holdings Co., Ltd. Business Overview
7.10.3 Otsuka Holdings Co., Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Major Product Offerings
7.10.4 Otsuka Holdings Co., Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales and Revenue in Global (2018-2023)
7.10.5 Otsuka Holdings Co., Ltd. Key News & Latest Developments
8 Global Chemotherapy-Induced Nausea and Vomiting Drugs Production Capacity, Analysis
8.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Production Capacity, 2018-2032
8.2 Chemotherapy-Induced Nausea and Vomiting Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Chemotherapy-Induced Nausea and Vomiting Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Chemotherapy-Induced Nausea and Vomiting Drugs Supply Chain Analysis
10.1 Chemotherapy-Induced Nausea and Vomiting Drugs Industry Value Chain
10.2 Chemotherapy-Induced Nausea and Vomiting Drugs Upstream Market
10.3 Chemotherapy-Induced Nausea and Vomiting Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Chemotherapy-Induced Nausea and Vomiting Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer